Bielesz, B.; Reiter, T.; Hammerle, F.P.; Winnicki, W.; Bojic, M.; Gleiss, A.; Kieweg, H.; Ratzinger, F.; Sunder-Plassmann, G.; Marculescu, R.
The Role of Iron and Erythropoietin in the Association of Fibroblast Growth Factor 23 with Anemia in Chronic Kidney Disease in Humans. J. Clin. Med. 2020, 9, 2640.
https://doi.org/10.3390/jcm9082640
AMA Style
Bielesz B, Reiter T, Hammerle FP, Winnicki W, Bojic M, Gleiss A, Kieweg H, Ratzinger F, Sunder-Plassmann G, Marculescu R.
The Role of Iron and Erythropoietin in the Association of Fibroblast Growth Factor 23 with Anemia in Chronic Kidney Disease in Humans. Journal of Clinical Medicine. 2020; 9(8):2640.
https://doi.org/10.3390/jcm9082640
Chicago/Turabian Style
Bielesz, Bernhard, Thomas Reiter, Fabian Peter Hammerle, Wolfgang Winnicki, Marija Bojic, Andreas Gleiss, Heidi Kieweg, Franz Ratzinger, Gere Sunder-Plassmann, and Rodrig Marculescu.
2020. "The Role of Iron and Erythropoietin in the Association of Fibroblast Growth Factor 23 with Anemia in Chronic Kidney Disease in Humans" Journal of Clinical Medicine 9, no. 8: 2640.
https://doi.org/10.3390/jcm9082640
APA Style
Bielesz, B., Reiter, T., Hammerle, F. P., Winnicki, W., Bojic, M., Gleiss, A., Kieweg, H., Ratzinger, F., Sunder-Plassmann, G., & Marculescu, R.
(2020). The Role of Iron and Erythropoietin in the Association of Fibroblast Growth Factor 23 with Anemia in Chronic Kidney Disease in Humans. Journal of Clinical Medicine, 9(8), 2640.
https://doi.org/10.3390/jcm9082640